Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

German industry demands tighter reconditioning laws

This article was originally published in Clinica

Executive Summary

If more efficient market surveillance reveals that those who process medical devices are unable to conform to the requirements, then we will have to consider further legal restrictions." This was the sentiment expressed by Hans Georg Will at last week's BVMed conference as he sought to tackle the problem of hospital in-house manufacturing and the reconditioning of medical devices in light of the second amendment of the medical device law (MPG - see this issue, p5).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT074016

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel